Clinical trialNCT01557842TerminatedPhase 4Interventional

Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators

SponsorBiosense Webster, Inc.Enrollment15IschemicVentricular Tachycardia

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if early ablation (i.e., ablation of ventricular tachycardia in patients with infrequent VT episodes) is more effective than medical therapy alone for the treatment of ischemic ventricular tachycardia in patients with Implantable Cardioverter Defibrillators (ICDs) who continue to have episodes of ventricular tachycardia despite drug therapy.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrea Natale, MD
Texas Cardiac Arrhythmia Research Foundation
Study Chair
clinicaltrials.gov ↗
David Callans, MD
University of Pennsylvania
Study ChairKOL profile →
clinicaltrials.gov ↗
David Wilber, MD
Loyola University
Study ChairKOL profile →
clinicaltrials.gov ↗
Francis Marchlinski, MD
University of Pennsylvania
Study ChairKOL profile →
clinicaltrials.gov ↗
Vivek Reddy, MD
Icahn School of Medicine at Mount Sinai
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, Los Angeles
Los Angeles, California, United States
California Pacific Medical Center
San Francisco, California, United States
San Francisco Va Medical Center
San Francisco, California, United States
University of California, San Francisco
San Francisco, California, United States
University of Colorado, Denver
Aurora, Colorado, United States
Florida Hospital
Orlando, Florida, United States
Loyola University Chicago
Maywood, Illinois, United States
Central Baptist Hospital
Lexington, Kentucky, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
University of Maryland
Baltimore, Maryland, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Brigham and Women'S Hospital
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Columbia University- New York Presbyterian Hospital
New York, New York, United States
Mount Sinai School of Medicine
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Ohio State University
Columbus, Ohio, United States
University of Oklahoma
Oklahoma City, Oklahoma, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Texas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
St. Luke'S Medical Center
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Drug Treatment

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Jun 2012
Primary completion: 19 Mar 2014
Completion: 19 Mar 2014
Last update posted: 8 Jun 2017
Registered enrollment: 15
Registry id: NCT01557842

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.